Concepedia

Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma

Corrado Tarella, Roberto Passera, Michele Magni, Fabio Benedetti, Andrea Rossi, Angela Gueli, Caterina Patti, Guido Parvis, Fabio Ciceri, Andrea Gallamini,

Journal of Clinical Oncology · 2010 · 166 citations · 32 references

DOIFull text

Open access

Abstract

This analysis has relevant implications for the design and use of intensive chemoimmunotherapy with autograft. In addition, it offers useful insights toward the understanding and prevention of tumor development.

References

32

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Jason P. Fine · Journal of the American Statistical Association · 1999 · 13.2K citations

, , +21

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

The Annals of Statistics · 1988 · 4.9K citations · Full text

, , +13

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

AlessandroM. Gianni, Marco Bregni, A. Stern et al. · The Lancet · 1989 · 750 citations

, , +10

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

Norbert Schmitz, Peter Dreger, David C. Linch et al. · The Lancet · 1996 · 615 citations

, , +10

Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

Andreas Engert, Volker Diehl, Jeremy Franklin et al. · Journal of Clinical Oncology · 2009 · 494 citations · Full text